Gene expression signature of human HepG2 cell line
Authors:
- S. CostantiniSCS. Costantini
- G. Di BernardoG. Di Bernardo
- M. CammarotaMCM. Cammarota
- G. CastelloGCG. Castello
- G. ColonnaGCG. Colonna
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsiesGut, 2011
- HCV-related hepatocellular carcinoma: From chronic inflammation to cancerClinical Immunology, 2010
- GLUT1 as a therapeutic target in hepatocellular carcinomaExpert Opinion on Therapeutic Targets, 2009
- Disruption of the Ang II type 1 receptor promotes longevity in miceJournal of Clinical Investigation, 2009
- Transcriptome classification of HCC is related to gene alterations and to new therapeutic targetsHepatology, 2006
- IL-4R signaling is required to induce IL-10 for the establishment of Th2 dominanceInternational Immunology, 2006
- Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironmentCancer Cell, 2006
- Positional expression profiling indicates candidate genes in deletion hotspots of hepatocellular carcinomaLaboratory Investigation, 2006
- Isolation, characterization, and chromosomal mapping of a novel cDNA clone encoding human selenium binding proteinJournal of Cellular Biochemistry, 1997
- DNA sequencing of a mouse liver protein that binds selenium: implications for selenium's mechanism of action in cancer preventionCarcinogenesis, 1990